TACHIPIRINA EARLY CHILDHOOD 125 MG SUPPOSITORIES 10 SUPPOSITORIES

Name
TACHIPIRINA Neonati 62.5 mg suppositories
TACHIPIRINA Early Childhood 125 mg suppositories
Paracetamol


What is it and what is it for?
Tachipirina contains the active ingredient paracetamol which works by reducing fever (antipyretic) and relieving pain (analgesic).
Tachipirina neonato and Tachipirina prima infanzia must be used in children with a body weight between 3.2 and 12 kg for:
- the symptomatic treatment of febrile conditions such as influenza, exanthematous diseases (infectious diseases typical of children and adolescents), acute respiratory tract diseases, etc.;
- pain of various origins and natures (headaches, neuralgia, muscle pain and other moderately severe painful symptoms).

Contact your doctor if your child does not feel better or if he or she feels worse after 3 days of treatment.


What you need to know before taking the medicine
Do not give the child Tylenol
- if you are allergic to paracetamol or any of the other ingredients of this medicine (listed in section 6);
- if you suffer from severe haemolytic anaemia (destruction of red blood cells);
- if you suffer from severe liver disease (severe hepatocellular insufficiency).




Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

If your child experiences the following side effects STOP treatment with this medicine and contact your doctor immediately :
• allergic reactions with :
- redness of the skin accompanied by itching (hives);
- swelling of the throat (laryngeal edema);
- swelling of the hands, feet, ankles, face, lips, tongue and/or throat (angioedema);
- severe allergic reaction (anaphylactic shock).

Furthermore, people taking this medicine may experience the following side effects, for which there are not enough data to establish the frequency.

• reduction in the number of platelets in the blood (thrombocytopenia);
• reduction in the number of white blood cells in the blood (leukopenia/agranulocytosis);
• reduction of hemoglobin in the blood, the substance that carries oxygen in the blood (anemia);
• dizziness;
• stomach and intestinal reactions;
• abnormal liver function;
• inflammation of the liver (hepatitis);
• red spots, bullous lesions with areas of skin detachment, blisters, skin rashes (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis);
• reduction in kidney function (acute renal failure);
• inflammation of the kidneys (interstitial nephritis);
• blood in the urine (hematuria);
• cessation or reduction of urine production by the kidney (anuria);
• a serious condition that can make the blood more acidic (called metabolic acidosis), in patients with a serious illness who use paracetamol (see section 2).

Very rare cases of serious skin reactions have been reported.

Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.